Siemens Healthineers will leverage its regional network and healthcare technology expertise to support the adoption of Aiforia's pathology tools.

The blood-based test detects phosphorylated tau 181, a biomarker that is correlated with the presence of amyloid pathology in the brain.

The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.

The company plans to conduct a three-year study of Parkinson's risk among people with essential tremor, using its Syn-One Test.

The new swab technology allows for non-invasive collection of patient samples without the need for liquids or complex devices.

The company noted that if PAMA cuts go into effect at the beginning of next year as scheduled, they would negatively impact its 2026 revenues by around $100 million.

The California-based firm said that its VeriClear EbV MARV Rapid Antigen Test will be used for the detection and differentiation of Ebola and Marburg virus infections.

Last week, readers were most interested in a story about alternatives to blood as sample types for diagnostic testing.

As the shutdown drags out, there could be delays in regulatory processes and payments for medical services as well as the ...

NEW YORK – Following a flurry of recent partnership and investment announcements, Hemex Health is transitioning from startup to scale-up phase. The developer of rapid point-of-care testing recently ...

The firm also reported a 3 percent increase in preliminary full-year 2025 revenues and announced the departure of its CFO.

A report that private equity firms and a group of banks were preparing bids for the firm drove up the price of Hologic's stock by as much as 4 percent on Thursday.